2-[2-(p-tolylsulfanyl)phenyl]acetic acid | 16174-75-7

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2-[2-(p-tolylsulfanyl)phenyl]acetic acid
• 英文别名: (2-p-tolylsulfanyl-phenyl)-acetic acid；(2-p-Tolylmercapto-phenyl)-essigsaeure；{2-[(4-methylphenyl)thio]phenyl}acetic acid；2-[2-(4-Methylphenyl)sulfanylphenyl]acetic acid
• CAS: 16174-75-7
• 化学式: C₁₅H₁₄O₂S
• 分子量: 258.341
• InChiKey: HMVVYKPBBHHBHJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  62.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-[2-(p-tolylsulfanyl)phenyl]acetic acid 在 titanium(III) chloride 、 草酰氯 、 W-2 Raney nickel 、 双氧水 、 三乙胺 、 N,N-二甲基甲酰胺 、 三氟乙酸酐 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 水 、 乙腈 、 苯 为溶剂， 反应 122.34h， 生成 5,6-dihydro-1-phenyl-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one
  参考文献：
  名称：

  Additive and Vinylogous Pummerer Reactions of Amido Sulfoxides and Their Use in the Preparation of Nitrogen Containing Heterocycles

  摘要：

  The alpha-thiocarbocation generated from the Pummerer re action of N-methyl-N-phenyl-2-[2-(toluene-4-sulfinyl)phenyl]acetamide undergoes Friedel-Crafts reaction at the gamma-carbon with the tethered aromatic ring. Reductive removal of the phenylthio group from the resulting product using Raney nickel occurs in high yield, and the overall reaction represents a new method for the synthesis of a variety of 3-phenyl-substituted oxindoles. Treatment of the related N-benzyl-N-alkyl amido sulfoxide system with trifluoroacetic anhydride affords tetrahydroisoquinolone derivatives. The product distribution encountered coincides with the rotamer population of the starting amide. When the N-benzyl-N-methyl amide is used, only the normal Pummerer product is formed. In this case, the thionium ion is generated in the wrong conformation for pi-cyclization to occur. The corresponding N-tert-butyl amido system, however, exists in a geometric orientation which places the benzylic group in the crucial conformation necessary for pi-cyclization, and consequently, the reaction proceeds smoothly. Related cyclization reactions occur in good yield with the corresponding furanyl and cyclohexenyl N-tert-butyl amido sulfoxides. The additive Pummerer reaction of 3-phenylsulfinyl-N-benzyl-N-tert-butylacrylamide gave products derived from both 5- and 6-exo trig cyclizations. Intramolecular electrophilic aromatic substitution via six-membered ring closure ultimately afforded a dihydropyridone. The competitive process involving ipso attack of the aromatic ring on the thionium ion generates a spiro cyclohexadienyl cation that undergoes fragmentation of the adjacent a-bond. The resulting acyl iminium ion is converted to N-tert-butyl-2-phenyl-3-phenylsulfinylacrylamide upon aqueous workup. Only cyclizations leading to five-membered rings occur with the corresponding indolyl and alkenyl N-tert-butyl amido sulfoxides.

  DOI：

  10.1021/jo972093h
• 作为产物：
  描述：

  2-(4'-甲基苯基硫烷基)苯甲酸 在 吡啶 、 氢氧化钾 、 lithium aluminium tetrahydride 、 氯化亚砜 作用下， 以 乙醚 、 乙醇 为溶剂， 生成 2-[2-(p-tolylsulfanyl)phenyl]acetic acid
  参考文献：
  名称：

  Pelz,K. et al., Collection of Czechoslovak Chemical Communications, 1968, vol. 33, # 6, p. 1895 - 1910

  摘要：

  DOI：

文献信息

• [EN] DIHYDROBENZO[B][1]BENZOTHIEPIN COMPOUNDS USEFUL IN THERAPY<br/>[FR] COMPOSÉS DE DIHYDROBENZO[B][1]BENZOTHIÉPINE UTILES EN THÉRAPIE
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2019092044A1

  公开（公告）日：2019-05-16

  The present invention relates to the use of a compound of formula (I), to decrease or inhibit, in vitro or ex vivo, the Patched receptor drug efflux activity, in particular the chemotherapeutic drug efflux activity and chemotherapy resistance. The present disclosure further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The compound of the invention can indeed be advantageously used, in combination with at least one chemotherapeutic drug, for treating cancer, for preventing cancer metastasis and/or for preventing cancer recurrence in a subject.

  本发明涉及使用式(I)的化合物，以减少或抑制体外或体外Patched受体药物外流活性，特别是化疗药物外流活性和化疗耐药性。本公开还涉及这类化合物的用途，特别是制备药物组合以允许或改善患有癌症的受试者的治疗效果。本发明的化合物确实可以有利地与至少一种化疗药物结合，用于治疗癌症，预防癌症转移和/或预防患者癌症复发。
• THIOARYL SUBSTITUTED INHIBITORS OF ZINC PROTEASES AND THEIR USE
  申请人：Rossello Armando

  公开号：US20090239829A1

  公开（公告）日：2009-09-24

  There are described compounds having the general formula (I) below and their pharmaceutically acceptable salts thereof, wherein E, X, m, q, R 1 , R 2 , n and ZBG have the meanings reported in the description useful, in therapy, as inhibitors of zinc metalloproteinases.

  描述了具有下面一般式（I）的化合物及其药学上可接受的盐，其中E、X、m、q、R1、R2、n和ZBG的含义如描述中所述，在治疗中作为锌金属蛋白酶的抑制剂。
• WO2008/61029
  申请人：——

  公开号：——

  公开（公告）日：——
• Phosphodiesters as GPR84 Antagonists for the Treatment of Ulcerative Colitis
  作者：Lin-Hai Chen、Qing Zhang、Yu-Feng Xiao、You-Chen Fang、Xin Xie、Fa-Jun Nan

  DOI：10.1021/acs.jmedchem.1c01813

  日期：2022.3.10
• Loudon et al., Journal of the Chemical Society, 1957, p. 3814,3816
  作者：Loudon et al.

  DOI：——

  日期：——